Lilly obesity drug beats Novo in study
Download and listen anywhere
Download your favorite episodes and enjoy them, wherever you are! Sign up or log in now to access offline listening.
Description
Tirzepatide 3x more likely to result in https://seekingalpha.com/news/4040661-eli-lilly-weight-loss-drug-outperforms-novo-nordisk?source=wsb_podcast:lilly_obesity_drug_beats_novo_in_study vs. semaglutide. (0:15) Consumer https://seekingalpha.com/news/4040744-consumer-confidence-bounces-back-after-three-straight-monthly-declines?source=wsb_podcast:lilly_obesity_drug_beats_novo_in_study pick up sharply in November. (1:38) Amazon takes https://seekingalpha.com/news/4040633-amazon-overtakes-ups-and-fedex-to-become-biggest-delivery-giant-in-the-us?source=wsb_podcast:lilly_obesity_drug_beats_novo_in_study from UPS, FedEx. (3:50) Show Notes https://seekingalpha.com/news/4040610-hedge-funds-ease-up-on-magnificent-7-binge?source=wsb_podcast:lilly_obesity_drug_beats_novo_in_study https://seekingalpha.com/news/4040629-adobe-figma-deal-likely-result-in-substantial-lessening-of-competition?source=wsb_podcast:lilly_obesity_drug_beats_novo_in_study...
show moreShow Notes
Hedge funds ease up on Magnificent 7 binge
Adobe, Figma deal likely to result in 'substantial lessening of competition'
Episode transcripts seekingalpha.com/wsb.
Sign up for our daily newsletter here and for full access to analyst ratings, stock quant scores, dividend grades, subscribe to Seeking Alpha Premium at seekingalpha.com/subscriptions.
Information
| Author | Seeking Alpha |
| Organization | Seeking Alpha |
| Website | seekingalpha.com |
| Tags |
Copyright 2024 - Spreaker Inc. an iHeartMedia Company
Comments